Sterling Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Global leader in steroidal APIs
One of their notable products is EXEMESTANE, with a corresponding US DMF Number 22439.
Remarkably, this DMF maintains an Active status since its submission on January 21, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 04, 2014, and payment made on October 20, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II